The advent of genetic engineering has allowed for the expression and p
roduction of recombinant proteins carrying short immunogenic epitopes
of foreign antigens. These antigenized molecules represent valuable to
ols to investigate the molecular basis of antigen fragmentation, gener
ation and presentation of peptide to lymphocytes, the induction of epi
tope specific immunity and potentially the development of a new genera
tion of vaccines. Recently, we expressed viral epitopes on immunoglobu
lin molecules by replacing the D segment of a variable region of the h
eavy chain (VH) gene with a B cell epitope from the V-3-loop of HIV-1
envelope protein, as well as a cytotoxic T lymphocyte (CTL) and a T he
lper epitope from influenza virus nucleoprotein and hemagglutinin, res
pectively. The T cell peptides generated from the immunoglobulin molec
ules produced by cells transfected with chimeric V genes, activated sp
ecific T cells as they do when generated from viral proteins. Possible
practical applications for the development of prophylactic and immuno
therapeutic reagents are envisioned for immunoglobulin molecules beari
ng foreign epitopes.